Results overview: Found 4 records in 0.01 seconds.
Articles, 4 records found
Articles 4 records found  
1.
11 p, 1.8 MB Guselkumab-Treated Patients with Plaque Psoriasis Who Achieved Complete Skin Clearance for ≥ 156 Consecutive Weeks : A Post-Hoc Analysis From the VOYAGE 1 Clinical Trial / Puig Sanz, Lluís (Institut d'Investigació Biomèdica Sant Pau) ; Costanzo, Antonio (Humanitas Clinical and Research Center IRCCS) ; de Jong, Elke M. G. J. (Radboud University Medical Center) ; Torres, Tiago (University of Porto) ; Warren, Richard B. (The University of Manchester) ; Wapenaar, Robert (Janssen-Cilag BV (Breda, Països Baixos)) ; Wegner, Sven (Janssen-Cilag GmbH (Neuss, Alemanya)) ; Gorecki, Patricia (Janssen-Cilag Ltd (High Wycombe, Regne Unit)) ; Gramiccia, Talia (Janssen-Cilag SpA (Milà, Itàlia)) ; Jazra, Maria (Janssen-Cilag (París, França)) ; Buyze, Jozefien (Janssen Pharmaceutica NV (Beerse, Bèlgica)) ; Conrad, Curdin (University of Lausanne) ; Universitat Autònoma de Barcelona
Treatment of moderate-to-severe plaque psoriasis with biologics, such as guselkumab, has demonstrated greater efficacy over traditional non-biologic treatments. However, given patient diversity, greater understanding of the relationship between patient characteristics, positive clinical outcomes, and long-term response to biologics is crucial for optimizing treatment choices. [...]
2023 - 10.1007/s40257-023-00816-1
American Journal of Clinical Dermatology, Vol. 25 (october 2023) , p. 315-325  
2.
9 p, 1.1 MB The biological basis of disease recurrence in psoriasis : a historical perspective and current models / Puig Sanz, Lluís (Institut d'Investigació Biomèdica Sant Pau) ; Costanzo, Antonio (Humanitas University) ; Muñoz-Elías, Ernesto J. (Janssen Research & Development) ; Jazra, Maria (Medical Affairs) ; Wegner, Sven (Janssen-Cilag GmbH) ; Paul, Carle (Hôpital Larrey) ; Conrad, Curdin (University Hospital CHUV) ; Universitat Autònoma de Barcelona
A key challenge in psoriasis therapy is the tendency for lesions to recur in previously affected anatomical locations after treatment discontinuation following lesion resolution. Available evidence supports the concept of a localized immunological 'memory' that persists in resolved skin after complete disappearance of visible inflammation, as well as the role of a specific subpopulation of T cells characterized by the dermotropic CCR4 phenotype and forming a local memory. [...]
2022 - 10.1111/bjd.20963
British journal of dermatology, Vol. 186 Núm. 5 (may 2022) , p. 773-781  
3.
10 p, 1.8 MB Network meta-analysis comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasis / Reich, Kristian (University Medical Center Hamburg-Eppendorf) ; Conrad, Curdin (University Hospital Lausanne CHUV) ; Kristensen, Lars Erik (Lund University) ; Smith, Saxon D. (The University of Sydney) ; Puig Sanz, Lluís (Institut d'Investigació Biomèdica Sant Pau) ; Rich, Phoebe (Oregon Dermatology and Research Center) ; Sapin, Christophe (Eli Lilly and Company) ; Holzkaemper, Thorsten (Eli Lilly and Company) ; Koppelhus, Uffe (Eli Lilly and Company) ; Schuster, Christopher (Medical University of Vienna) ; Universitat Autònoma de Barcelona
Nail psoriasis (NP) is common and of high importance in patients with psoriasis. Complete resolution of NP at week 24‒26 is an unambiguous nail outcome accessible for indirect treatment comparison of biologics. [...]
2022 - 10.1080/09546634.2021.1892024
Journal of Dermatological Treatment, Vol. 33 Núm. 3 (2022) , p. 1652-1660  
4.
3 p, 147.0 KB Integrated safety analysis of treatment-emergent eczematous reactions in patients with moderate-to-severe psoriasis treated with ixekizumab, etanercept and ustekinumab / Brunner, Patrik M. (Medical University of Vienna) ; Conrad, Curdin (Lausanne University Hospital) ; Vender, Ronald (Dermatrials Research Inc) ; Grond, Susanne (Eli Lilly and Company, Indianapolis) ; Schuster, Christopher F. (Eli Lilly and Company, Indianapolis) ; Patel, Hanna (Eli Lilly and Company, Indianapolis) ; Xu, Wen (Eli Lilly and Company, Indianapolis) ; Carrascosa, José Manuel (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Universitat Autònoma de Barcelona
2021 - 10.1111/bjd.20527
British journal of dermatology, Vol. 185 (august 2021) , p. 865-867  

See also: similar author names
1 Conrad, Christian
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.